Illumina reagents and services

The Florida Department of Health, Bureau of Public Health Laboratories, is seeking authorization for a single source purchase from Illumina, Inc. for reagents and services associated with the MiSeq, iSeq, and NextSeq systems. These resources are essential for the identification of nucleic acid sequences to support outbreak detection activities for viral and enteric diseases, as mandated by the Centers for Disease Control and Prevention. The procurement is justified under Chapter 60A-1.045 of the Florida Administrative Code because Illumina, Inc. is the sole manufacturer and provides the only CDC-approved kits for the specific pathogens being monitored. The estimated value of this contract is 4,258,653.30 dollars over a three-year period. This solicitation, identified by number EXP2696, is managed by the state of Florida with Keshauna Johnson serving as the primary point of contact. The performance of the contract will take place within the state of Florida to ensure the continued operational capacity of the Bureau of Public Health Laboratories in its critical public health surveillance missions.